Molecular assays to predict prognosis of breast cancer

Clinical Advances in Hematology and Oncology

Volumn 5, Issue 9, 2007, Pages 681-682

  Paik, Soonmyung ^a  

^a NSABP Foundation Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; ESTROGEN RECEPTOR; MOLECULAR MARKER; PROGESTERONE RECEPTOR; RNA; TAMOXIFEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; TUMOR MARKER; TUMOR PROTEIN;

ACCURACY; ADJUVANT THERAPY; ARTICLE; BREAST CANCER; CANCER HORMONE THERAPY; CANCER RESEARCH; CANCER SIZE; CLINICAL TRIAL; ECONOMIC ASPECT; GENE EXPRESSION PROFILING; GENETIC ALGORITHM; GENETIC ANALYSIS; HUMAN; IMMUNOHISTOCHEMISTRY; LIGAND BINDING; MICROARRAY ANALYSIS; MOLECULAR BIOLOGY; OUTCOMES RESEARCH; PHARMACOGENETICS; PREDICTION; PROGNOSIS; REPRODUCIBILITY; BIOSYNTHESIS; BREAST TUMOR; DNA MICROARRAY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; REVIEW;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CLINICAL TRIALS AS TOPIC; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; RNA, NEOPLASM; TAMOXIFEN; TUMOR MARKERS, BIOLOGICAL;

EID: 38449099068     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Paik S. Development and clinical utility of a 21-gene recurrence score prognostic assay in patients with early breast cancer treated with tamoxifen. Oncologist. 2007; 12:631-635.
2. Pusztai L, Cristofanilli M, Paik S. New generation of molecular prognostic and predictive tests for breast cancer. Semin Oncol. 2007;34(2 suppl 3):S10-S16.
3. Paik S, Tang G, Shak S, et al. Gene expression and benefit of chemotherapy in women with node negative, estrogen receptor-positive breast cancer. J Clin Oncol. 2006;24:3726-3734.
4. Paik S, Shak S, Tang G, et al. A multigene assay to predict recurrence of tamoxifentreated, node-negative breast cancer. N Engl J Med. 2004;351:2817-2826.
5. Come SE, Buzdar AU, Ingle JN, et al. Proceedings of the Fifth International Conference on Recent Advances and Future Directions in Endocrine Therapy for Breast Cancer: conference summary statement. Clin Cancer Res. 2006:12(3 pt 2):997s-1000s.
6. van't Veer LJ, Paik S, Hayes DF. Gene expression profiling of breast cancer: a new tumor marker. J Clin Oncol. 2005;23:1631-1635.